X

pharmaceuticals

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported double-digit growth in revenues and adjusted earnings for the fourth quarter…

Infographic: How Bristol Myers Squibb (BMY) performed in Q4 2023 financial results

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today. Total revenues inched up 1% to $11.5 billion…

ABBV Earnings: Everything you need to know about AbbVie’s Q4 report

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The…

Eli Lilly and Company all set to report Q4 results. Here’s what to expect

Pharmaceutical company Eli Lilly and Company (NYSE: LLY) is preparing to report fourth-quarter earnings. In recent years, the drugmaker successfully…

MRK Earnings: Highlights of Merck’s Q4 2023 financial results

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of…

Key takeaways from Pfizer’s (PFE) Q4 2023 earnings report

Shares of Pfizer Inc. (NYSE: PFE) were down 1% in midday trade on Tuesday. The stock has dropped 38% over…

PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2023 financial results

Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today. Revenues declined 41% year-over-year to $14.2 billion, missing estimates.…

Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report

Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results. Net income, excluding special…

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results

Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion.…

Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has…

MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023.…

Earnings Preview: What to look for when UnitedHealth reports Q4 results

Healthcare conglomerate UnitedHealth Group (NYSE: UNH) is preparing to publish fourth-quarter results on Friday. Over the years, the company has…

Earnings Summary: Highlights of DexCom’s Q4 2023 financial results

Healthcare company DexCom, Inc. (NASDAQ: DXCM) announced preliminary results for the fourth quarter of 2023, reporting an estimated double-digit increase…

Walgreens (WBA) to report Q1 results on Thursday. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is scheduled to report first-quarter earnings on Thursday, amid expectations for a mixed outcome.…

Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack…

Johnson & Johnson (JNJ) focuses on innovation after separating consumer business

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical…

Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth

Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite…

Earnings Summary: Highlights of Catalent’s Q1 2024 results

Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for…

Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research…

Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023.…

Gilead Sciences reports Q3 earnings. Here’s everything you need to know

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of…